Opposite regulation of cholesterol levels by the phosphatase and hydrolase domains of soluble epoxide hydrolase

Ahmed E. Enayetallah, Ayala Luria, Beibei Luo, Hsing Ju Tsai, Priyanka Sura, Bruce D. Hammock, David F. Grant

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Soluble epoxide hydrolase (sEH) is a bifunctional enzyme with two catalytic domains: a C-terminal epoxide hydrolase domain and an N-terminal phosphatase domain. Epidemiology and animal studies have attributed a variety of cardiovascular and anti-inflammatory effects to the C-terminal epoxide hydrolase domain. The recent association of sEH with cholesterol-related disorders, peroxisome proliferator-activated receptor activity, and the isoprenoid/cholesterol biosynthesis pathway additionally suggest a role of sEH in regulating cholesterol metabolism. Here we used sEH knock-out (sEH-KO) mice and transfected HepG2 cells to evaluate the phosphatase and hydrolase domains in regulating cholesterol levels. In sEH-KO male mice we found a ∼25% decrease in plasma total cholesterol as compared with wild type (sEH-WT) male mice. Consistent with plasma cholesterol levels, liver expression of HMG-CoA reductase was found to be ∼2-fold lower in sEH-KO male mice. Additionally, HepG2 cells stably expressing human sEH with phosphatase only or hydrolase only activity demonstrate independent and opposite roles of the two sEH domains. Whereas the phosphatase domain elevated cholesterol levels, the hydrolase domain lowered cholesterol levels. Hydrolase inhibitor treatment in sEH-WT male and female mice as well as HepG2 cells expressing human sEH resulted in higher cholesterol levels, thus mimicking the effect of expressing the phosphatase domain in HepG2 cells. In conclusion, we show that sEH regulates cholesterol levels in vivo and in vitro, and we propose the phosphatase domain as a potential therapeutic target in hypercholesterolemia-related disorders.

Original languageEnglish (US)
Pages (from-to)36592-36598
Number of pages7
JournalJournal of Biological Chemistry
Volume283
Issue number52
DOIs
StatePublished - Dec 26 2008

Fingerprint

Epoxide Hydrolases
Hydrolases
Phosphoric Monoester Hydrolases
Cholesterol
Hep G2 Cells
Hypercholesterolemia
Hydroxymethylglutaryl CoA Reductases
Peroxisome Proliferator-Activated Receptors
Plasmas
Terpenes
Epidemiology
Knockout Mice
Biosynthesis
Catalytic Domain
Metabolism
Liver
Anti-Inflammatory Agents

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Enayetallah, A. E., Luria, A., Luo, B., Tsai, H. J., Sura, P., Hammock, B. D., & Grant, D. F. (2008). Opposite regulation of cholesterol levels by the phosphatase and hydrolase domains of soluble epoxide hydrolase. Journal of Biological Chemistry, 283(52), 36592-36598. https://doi.org/10.1074/jbc.M806315200

Opposite regulation of cholesterol levels by the phosphatase and hydrolase domains of soluble epoxide hydrolase. / Enayetallah, Ahmed E.; Luria, Ayala; Luo, Beibei; Tsai, Hsing Ju; Sura, Priyanka; Hammock, Bruce D.; Grant, David F.

In: Journal of Biological Chemistry, Vol. 283, No. 52, 26.12.2008, p. 36592-36598.

Research output: Contribution to journalArticle

Enayetallah, AE, Luria, A, Luo, B, Tsai, HJ, Sura, P, Hammock, BD & Grant, DF 2008, 'Opposite regulation of cholesterol levels by the phosphatase and hydrolase domains of soluble epoxide hydrolase', Journal of Biological Chemistry, vol. 283, no. 52, pp. 36592-36598. https://doi.org/10.1074/jbc.M806315200
Enayetallah, Ahmed E. ; Luria, Ayala ; Luo, Beibei ; Tsai, Hsing Ju ; Sura, Priyanka ; Hammock, Bruce D. ; Grant, David F. / Opposite regulation of cholesterol levels by the phosphatase and hydrolase domains of soluble epoxide hydrolase. In: Journal of Biological Chemistry. 2008 ; Vol. 283, No. 52. pp. 36592-36598.
@article{1a6c366227f44628bf784b22987916d8,
title = "Opposite regulation of cholesterol levels by the phosphatase and hydrolase domains of soluble epoxide hydrolase",
abstract = "Soluble epoxide hydrolase (sEH) is a bifunctional enzyme with two catalytic domains: a C-terminal epoxide hydrolase domain and an N-terminal phosphatase domain. Epidemiology and animal studies have attributed a variety of cardiovascular and anti-inflammatory effects to the C-terminal epoxide hydrolase domain. The recent association of sEH with cholesterol-related disorders, peroxisome proliferator-activated receptor activity, and the isoprenoid/cholesterol biosynthesis pathway additionally suggest a role of sEH in regulating cholesterol metabolism. Here we used sEH knock-out (sEH-KO) mice and transfected HepG2 cells to evaluate the phosphatase and hydrolase domains in regulating cholesterol levels. In sEH-KO male mice we found a ∼25{\%} decrease in plasma total cholesterol as compared with wild type (sEH-WT) male mice. Consistent with plasma cholesterol levels, liver expression of HMG-CoA reductase was found to be ∼2-fold lower in sEH-KO male mice. Additionally, HepG2 cells stably expressing human sEH with phosphatase only or hydrolase only activity demonstrate independent and opposite roles of the two sEH domains. Whereas the phosphatase domain elevated cholesterol levels, the hydrolase domain lowered cholesterol levels. Hydrolase inhibitor treatment in sEH-WT male and female mice as well as HepG2 cells expressing human sEH resulted in higher cholesterol levels, thus mimicking the effect of expressing the phosphatase domain in HepG2 cells. In conclusion, we show that sEH regulates cholesterol levels in vivo and in vitro, and we propose the phosphatase domain as a potential therapeutic target in hypercholesterolemia-related disorders.",
author = "Enayetallah, {Ahmed E.} and Ayala Luria and Beibei Luo and Tsai, {Hsing Ju} and Priyanka Sura and Hammock, {Bruce D.} and Grant, {David F.}",
year = "2008",
month = "12",
day = "26",
doi = "10.1074/jbc.M806315200",
language = "English (US)",
volume = "283",
pages = "36592--36598",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "52",

}

TY - JOUR

T1 - Opposite regulation of cholesterol levels by the phosphatase and hydrolase domains of soluble epoxide hydrolase

AU - Enayetallah, Ahmed E.

AU - Luria, Ayala

AU - Luo, Beibei

AU - Tsai, Hsing Ju

AU - Sura, Priyanka

AU - Hammock, Bruce D.

AU - Grant, David F.

PY - 2008/12/26

Y1 - 2008/12/26

N2 - Soluble epoxide hydrolase (sEH) is a bifunctional enzyme with two catalytic domains: a C-terminal epoxide hydrolase domain and an N-terminal phosphatase domain. Epidemiology and animal studies have attributed a variety of cardiovascular and anti-inflammatory effects to the C-terminal epoxide hydrolase domain. The recent association of sEH with cholesterol-related disorders, peroxisome proliferator-activated receptor activity, and the isoprenoid/cholesterol biosynthesis pathway additionally suggest a role of sEH in regulating cholesterol metabolism. Here we used sEH knock-out (sEH-KO) mice and transfected HepG2 cells to evaluate the phosphatase and hydrolase domains in regulating cholesterol levels. In sEH-KO male mice we found a ∼25% decrease in plasma total cholesterol as compared with wild type (sEH-WT) male mice. Consistent with plasma cholesterol levels, liver expression of HMG-CoA reductase was found to be ∼2-fold lower in sEH-KO male mice. Additionally, HepG2 cells stably expressing human sEH with phosphatase only or hydrolase only activity demonstrate independent and opposite roles of the two sEH domains. Whereas the phosphatase domain elevated cholesterol levels, the hydrolase domain lowered cholesterol levels. Hydrolase inhibitor treatment in sEH-WT male and female mice as well as HepG2 cells expressing human sEH resulted in higher cholesterol levels, thus mimicking the effect of expressing the phosphatase domain in HepG2 cells. In conclusion, we show that sEH regulates cholesterol levels in vivo and in vitro, and we propose the phosphatase domain as a potential therapeutic target in hypercholesterolemia-related disorders.

AB - Soluble epoxide hydrolase (sEH) is a bifunctional enzyme with two catalytic domains: a C-terminal epoxide hydrolase domain and an N-terminal phosphatase domain. Epidemiology and animal studies have attributed a variety of cardiovascular and anti-inflammatory effects to the C-terminal epoxide hydrolase domain. The recent association of sEH with cholesterol-related disorders, peroxisome proliferator-activated receptor activity, and the isoprenoid/cholesterol biosynthesis pathway additionally suggest a role of sEH in regulating cholesterol metabolism. Here we used sEH knock-out (sEH-KO) mice and transfected HepG2 cells to evaluate the phosphatase and hydrolase domains in regulating cholesterol levels. In sEH-KO male mice we found a ∼25% decrease in plasma total cholesterol as compared with wild type (sEH-WT) male mice. Consistent with plasma cholesterol levels, liver expression of HMG-CoA reductase was found to be ∼2-fold lower in sEH-KO male mice. Additionally, HepG2 cells stably expressing human sEH with phosphatase only or hydrolase only activity demonstrate independent and opposite roles of the two sEH domains. Whereas the phosphatase domain elevated cholesterol levels, the hydrolase domain lowered cholesterol levels. Hydrolase inhibitor treatment in sEH-WT male and female mice as well as HepG2 cells expressing human sEH resulted in higher cholesterol levels, thus mimicking the effect of expressing the phosphatase domain in HepG2 cells. In conclusion, we show that sEH regulates cholesterol levels in vivo and in vitro, and we propose the phosphatase domain as a potential therapeutic target in hypercholesterolemia-related disorders.

UR - http://www.scopus.com/inward/record.url?scp=61349115586&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61349115586&partnerID=8YFLogxK

U2 - 10.1074/jbc.M806315200

DO - 10.1074/jbc.M806315200

M3 - Article

VL - 283

SP - 36592

EP - 36598

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 52

ER -